Free Trial

Top 4 Large-Cap Stocks With Major Short Interest

vials of covid-19 vaccine with syringes in the background Novavax Laboratory logo

Key Points

  • The ongoing GameStop saga has reignited interest in meme stocks, potentially leading traders and speculators to seek out stocks with high short interest.
  • As major market indices and leading tech stocks trade near all-time highs, traders are growing increasingly interested in risk and speculative plays.
  • Four of the most highly shorted, non-penny stocks include Novavax, Upstart, C3.ai, and Comstock Resources.
  • Five stocks to consider instead of Comstock Resources.
Remove Ads

With the ongoing GameStop saga reigniting interest in meme stocks, investors, or more likely traders and speculators, are once again seeking out stocks with high short interest. As the overall market, the technology sector, and many global-leading household stocks trade near all-time highs, trader's appetite for risk and speculative plays may be increasing.

That's where these four stocks, with a considerable short interest, come in. Here, we look closer at four highly shorted stocks that are not penny stocks, exploring whether they might experience significant moves due to their short interest levels. 

It's important to remember that investors often perceive heavily shorted stocks as fundamentally flawed, significantly overbought, and overvalued. Those who short these stocks typically believe the market has overpriced them relative to their financial health and growth prospects. So, while a stock with a high short interest could mean a short squeeze is looming, it should also raise an alarm bell for a potential investor. Take a look at four large-cap stocks with significant short interest below.

Novavax Inc.: A Leader in Vaccine Development

Novavax Today

Novavax, Inc. stock logo
NVAXNVAX 90-day performance
Novavax
$6.00 -0.41 (-6.40%)
As of 04/1/2025 04:00 PM Eastern
52-Week Range
$3.81
$23.86
Price Target
$18.00

Novavax NASDAQ: NVAX is a biotechnology company that develops vaccines and biological therapies to combat infectious diseases. The stock has surged an astounding 233% YTD, driven by a $1.3 billion deal and potential approval of its COVID-19 vaccine. On May 14, Novavax inked a licensing deal with Sanofi, including a $500 million upfront payment, up to $700 million in milestone payments, and a $70 million investment in Novavax stock. As of May 15, NVAX is one of the most shorted stocks, with a short interest of 32%, equating to 45 million shares sold short, up nearly 1% from the previous month. 

Upstart Holdings, Inc.: Revolutionizing AI-Powered Lending

Upstart Today

Upstart Holdings, Inc. stock logo
UPSTUPST 90-day performance
Upstart
$46.00 -0.03 (-0.07%)
As of 04/1/2025 04:00 PM Eastern
52-Week Range
$20.60
$96.43
Price Target
$73.38

Upstart Holdings NASDAQ: UPST, a leading fintech company, operates a cloud-based AI lending platform in the United States. The stock has a significant 34% short interest, increasing by 7% month-over-month. The stock is down nearly 42% YTD, with no signs of recovery, and has fallen almost 7% over the last month. Analysts remain bearish, with a consensus reduce rating and a price target predicting a further 9% downside.

Remove Ads

C3.ai, Inc.: Pioneering Enterprise AI Solutions

C3.ai Today

C3.ai, Inc. stock logo
AIAI 90-day performance
C3.ai
$21.44 +0.40 (+1.88%)
As of 04/1/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
52-Week Range
$18.85
$45.08
Price Target
$31.33

C3.ai NYSE: AI offers AI solutions for enterprise optimization and decision-making. Despite lagging the market with only a 9% YTD gain, the stock surged over 30% in the last month due to strong Q4 earnings, where revenue rose 20% year-over-year to $87 million. Despite these positive results, short interest remains high at 28%, or 34 million shares sold short, an increase of over 3% from the previous month. Analysts maintain a neutral stance with a consensus Hold rating and a price target close to the current stock price.

Comstock Resources, Inc.: Leading Independent Energy Company

Comstock Resources Today

Comstock Resources, Inc. stock logo
CRKCRK 90-day performance
Comstock Resources
$20.32 -0.02 (-0.08%)
As of 04/1/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
52-Week Range
$7.74
$22.06
Price Target
$13.73

Comstock Resources NYSE: CRK is an independent energy company focused on natural gas and oil production in the United States. CRK shares have risen nearly 36% YTD and almost 20% in the last month. Despite this performance, sentiment is bearish, with analysts maintaining a consensus Hold rating and a price target forecasting nearly 14% downside. The stock has a short interest of almost 35%. A notable factor is the lack of insider selling over the past year, with one insider purchasing $100 million worth of stock in Q1.

The Bottom Line on High Short Interest Stocks

As meme stock mania continues, stocks with high short interest, like Novavax, Upstart, C3.ai, and Comstock Resources, may attract renewed interest from those hoping for a short squeeze. Monitoring these stocks for potential short squeezes could provide valuable opportunities amid the broader market's strength. Still, it's also imperative to remember that a high short interest might signal an overbought scenario and potentially a fundamentally flawed company.

Should You Invest $1,000 in Comstock Resources Right Now?

Before you consider Comstock Resources, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Comstock Resources wasn't on the list.

While Comstock Resources currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Ryan Hasson
About The Author

Ryan Hasson

Contributing Author

Technical Analysis, Momentum Trading, Risk Management

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Upstart (UPST)
4.1186 of 5 stars
$46.00-0.1%N/A-31.51Hold$73.38
GameStop (GME)
2.0018 of 5 stars
$22.62+1.4%6.72%125.70Sell$10.00
C3.ai (AI)
4.249 of 5 stars
$21.45+1.9%4.20%-9.70Hold$31.33
Novavax (NVAX)
3.6619 of 5 stars
$6.00-6.4%N/A-2.65Hold$18.00
Comstock Resources (CRK)
2.0431 of 5 stars
$20.32-0.1%2.46%-26.74Reduce$13.73
Compare These Stocks  Add These Stocks to My Watchlist 

Remove Ads

Featured Articles and Offers

5 Stocks to BUY NOW in March 2025

5 Stocks to BUY NOW in March 2025

MarketBeat's Thomas Hughes looks at five stocks poised for gains this year that investors should have on their watchlists for buying opportunities in March.

Recent Videos

 5 Stocks to BUY NOW in April 2025
3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads